Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3)

BVMF:PFRM3 Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	229.55	193.74	183.26	188.52	371.79
Short-Term Investments	9.5	-	-	-	-
Cash & Short-Term Investments	239.06	193.74	183.26	188.52	371.79
Cash Growth	23.39%	5.72%	-2.79%	-49.30%	64.64%
Accounts Receivable	1,394	1,187	1,044	831.43	761.96
Other Receivables	454.96	600.78	498.23	448.16	403.15
Receivables	1,849	1,788	1,542	1,280	1,165
Inventory	1,820	1,528	1,236	1,085	903.84
Prepaid Expenses	-	10.43	6.61	8.72	9.32
Other Current Assets	111.88	19.66	13.16	20.55	34.08
Total Current Assets	4,020	3,539	2,980	2,582	2,484
Property, Plant & Equipment	674.18	535.59	507	519.02	392.62
Long-Term Investments	8.93	2.01	1.99	-	36.46
Goodwill	-	483.16	488.01	495.02	500.58
Other Intangible Assets	629.32	134.74	131.47	129.31	123.89
Long-Term Deferred Tax Assets	234.13	184.1	177.08	163.7	121.86
Other Long-Term Assets	49.6	58.96	78.96	143.84	101.51
Total Assets	5,616	4,938	4,365	4,033	3,761
Accounts Payable	2,195	1,820	1,486	1,286	1,146
Accrued Expenses	221.92	173.65	147.6	119.73	130.38
Current Portion of Long-Term Debt	248.54	206.28	131.02	117.65	167.47
Current Portion of Leases	110.67	92.51	90.91	89.18	66.75
Current Income Taxes Payable	-	2.29	0.18	0.15	0.08
Current Unearned Revenue	109.51	49.37	21.51	46.54	-
Other Current Liabilities	103.14	102.07	79.48	57.22	33.51
Total Current Liabilities	2,989	2,447	1,956	1,717	1,544
Long-Term Debt	551.18	573.63	532.65	440.8	433.64
Long-Term Leases	336.32	271.28	269.62	299.25	232.86
Long-Term Deferred Tax Liabilities	82.12	40.22	41.42	38.06	27.38
Other Long-Term Liabilities	71.66	67.13	54.33	62.02	88.11
Total Liabilities	4,030	3,399	2,854	2,557	2,326
Common Stock	918.66	1,044	1,044	1,044	1,044
Retained Earnings	224.15	180.07	156.97	97.35	52.33
Treasury Stock	-16.37	-16.37	-16.37	-16.37	-16.37
Comprehensive Income & Other	176.66	40.98	6.74	-38.58	-33.31
Total Common Equity	1,303	1,248	1,191	1,086	1,046
Minority Interest	282.72	290.68	319.58	389.82	388.9
Shareholders' Equity	1,586	1,539	1,511	1,476	1,435
Total Liabilities & Equity	5,616	4,938	4,365	4,033	3,761
Total Debt	1,247	1,144	1,024	946.88	900.72
Net Cash (Debt)	-1,008	-949.96	-840.94	-758.37	-528.93
Net Cash Per Share	-8.21	-7.75	-6.86	-6.19	-4.31
Filing Date Shares Outstanding	122.87	122.61	122.61	122.61	122.61
Total Common Shares Outstanding	122.87	122.61	122.61	122.61	122.61
Working Capital	1,031	1,093	1,024	865.12	940.29
Book Value Per Share	10.61	10.18	9.71	8.86	8.53
Tangible Book Value	673.79	630.44	571.54	461.74	421.85
Tangible Book Value Per Share	5.48	5.14	4.66	3.77	3.44
Machinery	-	236.64	215.69	194.07	173.49
Construction In Progress	-	14.23	6.22	9.33	7.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.